Literature DB >> 9165218

Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits.

B G Nordestgaard1, B Agerholm-Larsen, S Stender.   

Abstract

To examine the hypothesis that hyperinsulinaemia promotes atherosclerosis, cholesterol-fed rabbits were injected subcutaneously with 6 i.u. of human insulin (n = 16) or placebo (n = 20) daily for 24 weeks; injection of insulin resulted in hyperinsulinaemia for up to 16 h after injection. Compared to placebo rabbits, insulin-treated rabbits had higher levels of insulin antibodies in plasma, similar levels of intermediate density, low density and high density lipoprotein cholesterol and similar activities of hepatic and lipoprotein lipase in post-heparin plasma, but lower levels of plasma C-peptide, blood glucose, postprandial plasma triglycerides, plasma cholesterol and very low density lipoprotein cholesterol. On univariate analysis, with and without adjustment for differences in plasma cholesterol levels between the two groups, there were no significant differences in extent or severity of atherosclerosis between insulin and placebo rabbits. Furthermore, after combining the results from all the rabbits to examine plasma insulin levels and the other variables mentioned above as predictors of atherosclerosis severity, plasma insulin level was not a predictor, on univariate or multiple linear regression analysis; the first ranked independent predictors were postprandial intermediate density lipoprotein cholesterol in the arch, and postprandial plasma triglyceride in both the thoracic and abdominal aorta. These results suggest that exogenous hyperinsulinaemia does not promote atherogenesis in cholesterol-fed rabbits, but that postprandial levels of intermediate density lipoprotein cholesterol or plasma triglycerides may be involved in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165218     DOI: 10.1007/s001250050709

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  7 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Glycemic reduction alters white blood cell counts and inflammatory gene expression in diabetes.

Authors:  Xiang Fang; Brenda Dorcely; Xi-Ping Ding; Shi Yin; Ni-Huiping Son; Shi-Lian Hu; Ira J Goldberg
Journal:  J Diabetes Complications       Date:  2018-08-04       Impact factor: 2.852

3.  Intestinal and systemic effects of oral insulin supplementation in rats after weaning.

Authors:  Raanan Shamir; Muhamed Muslach; Igor Sukhotnik; Rina Perlman; Eric Diamond; Jorge Mogilner; Naim Shehadeh
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 4.  Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.

Authors:  A Evans; A J Krentz
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

5.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

6.  Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR).

Authors:  Flavio E Hirai; Scot E Moss; Barbara E K Klein; Ronald Klein
Journal:  Diabetes Care       Date:  2007-11-19       Impact factor: 19.112

7.  Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.

Authors:  W Frick; A Bauer; J Bauer; S Wied; G Müller
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.